Press Releases


July 2, 2014 - Collegium Pharmaceutical Announces Issuance of U.S. Patent Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
June 5, 2014 - Collegium Announces Poster Presentations for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Analgesic at the 2014 International Conference on Opioids
May 29, 2014 - Collegium Pharmaceutical Advances Development Program for Hydrocodone DETERx®, an Abuse-Deterrent, Extended-Release Analgesic for the Treatment of Chronic Pain
May 27, 2014 - Collegium Pharmaceutical to Present at the Jefferies 2014 Global Healthcare Conference in New York on June 3, 2014
May 13, 2014 - Collegium Pharmaceutical’s CEO to Present at the UBS 2014 Global Healthcare Conference in New York on May 21, 2014
April 29, 2014 - Collegium Pharmaceutical Announces Successful Pre-NDA Meeting with FDA for Oxycodone DETERx®, its Extended-Release, Abuse-Deterrent Product for the Treatment of Chronic Pain
April 2, 2014 - Collegium Pharmaceutical Announces Positive Topline Results of Clinical Study Evaluating the Effect of Crushing Oxycodone DETERx® Compared with OxyContin®
March 19, 2014 - Collegium Pharmaceutical Announces Allowance of New Claims Covering DETERx®, an Abuse-Deterrent, Extended-Release, Technology Platform
February 4, 2014 - Collegium Pharmaceutical Announces Completion of Enrollment in Pivotal Phase 3 Clinical Study for Oxycodone DETERx®, its Lead Abuse-Deterrent Development Program
January 15, 2014 - Collegium Pharmaceutical Announces Positive Topline Results of Human Abuse Potential Study Evaluating Intranasal Administration of Crushed Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Product
October 29, 2013 -“Challenges of Treating Patients with Chronic Pain with Dysphagia (CPD): Physician and Patient Perspectives,” Published in Peer-Reviewed Medical Journal
October 17, 2013 - Collegium Pharmaceutical Announces Issuance of U.S. Patent and Allowance of New Claims Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
September 3, 2013 - Collegium Pharmaceutical’s Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid, to be featured at PAINWeek 2013
July 24, 2013 - Collegium Pharmaceutical Announces Successful Completion of Clinical Study Evaluating Intranasal Administration of Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
July 18, 2013 - Collegium Pharmaceutical, Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
June 20, 2013 - Collegium Pharmaceutical, Inc. Announces Issuance of an Additional U.S. Patent Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
May 31, 2013 - Collegium Pharmaceutical’s CEO to Present at the Jefferies 2013 Global Health Care Conference in New York on June 4, 2013
May 17, 2013 - Collegium Pharmaceutical’s CEO to Present at the UBS Global Health Care Conference in New York on May 20, 2013
May 8, 2013 - Collegium Announces Poster Presentation for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid at American Pain Society’s 32nd Annual Scientific Meeting
April 30, 2013 - Collegium Announces Results of Chronic Pain Patient Survey – Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid